Mark P. Chao
Impact in
- Immunology top 0.2%
- Phagocytosis and Immune Regulation
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
Papers in
- Immunology 50
- Phagocytosis and Immune Regulation 48
- Immune cells in cancer 12
- Immunotherapy and Immune Responses 8
- Co-authors
- Irving L. Weissman (33 shared papers)Ravindra Majeti (29 shared papers)Siddhartha Jaiswal (6 shared papers)Ash A. Alizadeh (8 shared papers)Wendy W. Pang (5 shared papers)Nico van Rooijen (2 shared papers)Christopher Y. Park (5 shared papers)Kenneth D. Gibbs (2 shared papers)
- Journals
- Blood (15 papers)Journal of Clinical Oncology (15 papers)Cell (3 papers)Proceedings of the National Academy of Sciences (3 papers)Cancer Immunology Research (2 papers)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Mark P. Chao
72 papers receiving 8.5k citations
Mark P. Chao's Hit Papers
Peers
Comparison fields: 5 of 113
- Immunology 5.2k
- Hematology 1.5k
- Oncology 2.4k
- Genetics 590
- Physiology 1.1k
Countries citing papers authored by Mark P. Chao
This map shows the geographic impact of Mark P. Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Chao more than expected).
Fields of papers citing papers by Mark P. Chao
This network shows the impact of papers produced by Mark P. Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Chao. The network helps show where Mark P. Chao may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark P. Chao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells Hit paper breakdown → | 2009 | 1362 |
| 2 | CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis Hit paper breakdown → | 2009 | 1231 |
| 3 | Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma Hit paper breakdown → | 2010 | 858 |
| 4 | Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47 Hit paper breakdown → | 2010 | 604 |
| 5 | Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells Hit paper breakdown → | 2009 | 516 |
| 6 | The CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implications Hit paper breakdown → | 2012 | 515 |
| 7 | 2015 | 388 | |
| 8 | 2010 | 301 | |
| 9 | 2011 | 245 | |
| 10 | 2006 | 211 | |
| 11 | 2010 | 205 | |
| 12 | 2011 | 197 | |
| 13 | 2020 | 191 | |
| 14 | 2019 | 167 | |
| 15 | 2011 | 155 | |
| 16 | 2012 | 123 | |
| 17 | 2008 | 101 | |
| 18 | Energy-Dense versus Routine Enteral Nutrition in the Critically Ill | 2019 | 100 |
| 19 | 2019 | 95 | |
| 20 | 2017 | 93 |
About Mark P. Chao
Mark P. Chao is a scholar working on Immunology, Molecular Biology, Hematology, Oncology and Physiology, having authored 74 papers that have together received 8.6k indexed citations. Recurring topics across this work include Phagocytosis and Immune Regulation (48 papers), Acute Myeloid Leukemia Research (17 papers), Erythrocyte Function and Pathophysiology (13 papers), Immune cells in cancer (12 papers), CAR-T cell therapy research (11 papers), Chronic Lymphocytic Leukemia Research (10 papers), Immunotherapy and Immune Responses (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). The work is most often cited by research in Immunology (5.2k citations), Hematology (1.5k citations), Oncology (2.4k citations), Genetics (590 citations) and Physiology (1.1k citations). Mark P. Chao has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Irving L. Weissman, Ravindra Majeti, Siddhartha Jaiswal, Ash A. Alizadeh, Wendy W. Pang, Nico van Rooijen, Christopher Y. Park, Kenneth D. Gibbs, Catriona Jamieson and David Traver. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cell, Proceedings of the National Academy of Sciences and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.